Evidence map›Paper›PMID 29574937›Full record

ArticleInternational journal of cancer2018

Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.

Bryan A Bassig, Martina Willhauck-Fleckenstein, Xiao-Ou Shu, Woon-Puay Koh, Yu-Tang Gao, Mark P Purdue, Yong-Bing Xiang, Jennifer Adams-Haduch, Renwei Wang, Nicole Brenner and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma.Journal of acquired immune deficiency syndromes (1999) · 2019
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 10 institutions in 4 countries.

Bryan A BassigDivision of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Rockville, MD.ORCID 0000-0002-0278-8597
Martina Willhauck-FleckensteinDivision of Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Xiao-Ou ShuDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN.
Woon-Puay KohHealth Services & Systems Research, Duke-NUS Medical School, Singapore.
Yu-Tang GaoDepartment of Epidemiology, Shanghai Cancer Institute, Shanghai Jiaotong University, Shanghai, China.
Mark P PurdueDivision of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Rockville, MD.
Yong-Bing XiangState Key Laboratory of Oncogene and Related Genes & Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Jennifer Adams-HaduchDivision of Cancer Control and Population Sciences, University of Pittsburgh Cancer Institute, Pittsburgh, PA.
Renwei WangDivision of Cancer Control and Population Sciences, University of Pittsburgh Cancer Institute, Pittsburgh, PA.
Nicole BrennerDivision of Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tim WaterboerDivision of Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Angelika MichelDivision of Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Bu-Tian JiDivision of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Rockville, MD.
H Dean HosgoodDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, NY.
Charles S RabkinDivision of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Rockville, MD.
Gong YangDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN.
Jason Y Y WongDivision of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Rockville, MD.
Jinming ZhangDivision of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Rockville, MD.
Wei HuDivision of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Rockville, MD.
Wei Jie SeowSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
Wong-Ho ChowDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Michael PawlitaDivision of Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN.
Jian-Min YuanDivision of Cancer Control and Population Sciences, University of Pittsburgh Cancer Institute, Pittsburgh, PA.
Qing LanDivision of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Rockville, MD.
Nathaniel RothmanDivision of Cancer Epidemiology and Genetics, NCI, NIH, DHHS, Rockville, MD.
United States Department of Health and Human Services · USGerman Cancer Research Center · DEVanderbilt University · USNational University of Singapore · SGUPMC Hillman Cancer Center · USAlbert Einstein College of Medicine · USRenji Hospital · CNShanghai Cancer Institute · CNThe University of Texas MD Anderson Cancer Center · USUniversity of Pittsburgh · US

Funding

Occupational and Environmental Determinants of Cancer among Women and MinoritiesZIACP010123 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI HOFMANN, JONATHAN · 2009 to 2025
$8.3M
Prospective studies of cancer etiology and prevention in Shanghai and SingaporeR01CA144034 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2010 to 2014
$7.0M
Shanghai Womens Health StudyUM1CA182910 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2014 to 2018
$5.9M
Shanghai Men's Health StudyUM1CA173640 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHU, XIAO-OU · 2013 to 2017
$4.9M
Cancer Risk Reduction and Diet: A Cohort Study of WomenR37CA070867 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2009 to 2013
$4.7M
Cancer epidemiology cohorts in Shanghai and Singapore UM1CA182876 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2014 to 2018
$4.3M
NCI NIH HHS R01 CA144034NCI NIH HHS R37 CA070867NCI NIH HHS UM1 CA173640NCI NIH HHS UM1 CA182876NCI NIH HHS UM1 CA182910
6 · The paper itself

Abstract

Incidence rates of non-Hodgkin lymphoma (NHL) and distributions of certain viruses differ between East Asian and Western populations. There are limited data on associations between serologic markers of multiple viral infections in pre-diagnostic blood and NHL risk in East Asians. We conducted a nested case-control study of 214 NHL cases and 214 matched controls from three population-based prospective cohorts in Shanghai and Singapore. Antibodies against antigens from herpesviruses, Hepatitis B (HBV) and C (HCV) virus and polyomaviruses were measured in plasma or serum using fluorescent bead-based multiplex assays. Conditional logistic regression was used to evaluate associations between antibody levels and NHL risk. An increased risk of NHL was observed for higher compared to lower EA-D (Odds Ratio (OR) = 2.04, 95% Confidence Interval (CI) = 1.10-3.81; p

Indexed as

AgedBiomarkersCase-Control StudiesChinaFemaleHumansLymphoma, Non-HodgkinMaleMiddle AgedOdds RatioPopulation SurveillanceRisk AssessmentRisk FactorsSingaporeVirus DiseasesBiomarkersEpstein-Barr virushepatitismultiplex serologynon-Hodgkin lymphomaviral antibodies

Identifiers

PMID29574937
PMCPMC11423783
OpenAlexW2792700798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.